Do you want to skip to content? Skip to content
България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق Australia Australia India India Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Indonesia Indonesia 日本 日本 대한민국 대한민국 ไทย ไทย Việt Nam Việt Nam 中国大陆 中国大陆 中国香港特别行政区 中国香港特别行政区 中国台湾 中国台湾
False /oidc-signin/en-gb/ България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق Australia Australia India India Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Indonesia Indonesia 日本 日本 대한민국 대한민국 ไทย ไทย Việt Nam Việt Nam 中国大陆 中国大陆 中国香港特别行政区 中国香港特别行政区 中国台湾 中国台湾

What NICE guidance means for antimicrobial wound dressings

22/08/2025
an image of aquacel ag+ extra on a green and blue background ;

We’re excited to share that the latest evaluation from the National Institute for Health and Care Excellence (NICE) provides important clarity on the use of topical antimicrobial dressings such as Aquacel® Ag+ Extra™ for infected leg ulcers.

The guidance forms part of NICE’s Late-Stage Assessment (LSA) framework, which evaluates categories of technologies already in widespread NHS use within the UK and Ireland.

Key findings:¹⁻²

  1. Silver agents assumed to be used up to 12 weeks
  2. Evidence favours silver agents for achieving complete wound healing
  3. The faster patients progress to healing, the more likely that outcome will be cost-effective

What does the NICE LSA say?

The LSA looked at a range of clinical evidence, including randomised controlled trials (RCTs), real-world case studies, and expert opinion. Aquacel® Ag+ Extra™, with its three-component formula, was identified as a dressing that may offer better patient outcomes and faster healing times in the presence of infection risk.

NICE's LSA highlights Aquacel® Ag+ Extra™ as a clinically effective and potentially cost-saving solution for wounds where infection or biofilm is suspected. Its evaluation recognised that certain silver dressings, particularly those designed with biofilm-disrupting technologies, such as More Than Silver™ technology can play a vital role in hard-to-heal wound care.

Why this matters for HCPs

With increasing focus on antimicrobial stewardship, many clinicians have been cautious about silver dressings, including the long-standing myth that silver-containing dressings can only be used for 2 weeks. 

NICE’s latest review provides reassurance that, when used appropriately, dressings like Aquacel® Ag+ Extra™ offer measurable benefits and are assumed for use for 12 weeks, reviewing every 2 weeks and to keep using if needed.³

The biofilm battle

Biofilms are mixed communities of bacteria and other microorganisms living together⁴ and when free floating bacteria attach to a surface, this is when they can begin forming a biofilm. Biofilm is a major barrier to wound healing, thought to be present in almost 8 out of 10 hard-to-heal wounds⁵ – therefore it should be assumed present in every hard-to-heal wound.⁶

Biofilm is not always visible to the naked eye⁷ and can be difficult to remove, even after aggressive debridement, even reforming within 24 hours.⁸

When to use Aquacel® Ag+ Extra™

The 3 components of Aquacel® Ag+ Extra™ with its More Than Silver™ technology, ensure that it’s specifically designed to address the issue of biofilm and contribute to wound healing.

  1. Chelating agent to disrupt, breaking down biofilm matrix⁹⁻¹¹
  2. Surfactant to weaken, loosen and remove biofilm allowing absorption by the dressing¹⁰⁻¹³ 
  3. 1.2% ionic silver, a broad spectrum antimicrobial

Aquacel® Ag+ Extra™ in action

Baseline: 14-year old static wound

-    Venous insufficiency
-    Maanged with cleansing, debriding and antimicrobial dressings
-    Compression and superabsorbent cover dressing for exudate

Intervention: 6 weeks with Aquacel® Ag+ Extra™

-    Exudate managed with Hydrofiber®, reduced peri-wound maceration
-    Healthy granulation formed, epithelialisation started
-    Static wound progressing to healing

When to choose Aquacel® Ag+ Extra™

Managing wounds appropriately with Aquacel® Ag+ Extra™ gives your patients the chance to heal wounds

Key Takeaways

Silver dressings are not all created equally. NICE's LSA affirms that targeted use of advanced antimicrobial dressings like Aquacel® Ag+ Extra™ is supported by robust evidence and can be a significant dressing in infection and biofilm management.

References

1. Holmes et al [GID-HTE10041] – Topical Antimicrobial Dressings for Infected Leg Ulcers in People 16 and over. Second Addendum; NICE, York Health Economic Consortium. 2025.

2. Holmes et al [GID-HTE10041] – Topical Antimicrobial Dressings for Infected Leg Ulcers in People 16 and over. External Assessment Group Report; NICE, York Health Economic Consortium. 2025.

3. International Wound Infection Institute (IWII) Wound Infection in Clinical Practice. Wounds International. 2022.

4. Stewart. Microbiol Spectr. 2015;3(3).

5. Malone et al, J Wound Care. 2017;26(1):20-25.

6. Murphy et al, J Wound Care. 2020;29(Suppl 3b):S1-28.

7. International Wound Infection Institute (IWII) Wound Infection in Clinical Practice. Wounds International, 2022.

8.  Wolcott et al. J Wound Care. 2010;19(8):320-328.

9. Banin 2006, Chelator Induced Dispersal and Killing of Pseudomonas aeruginosa Cells in Biofilm

10. Parsons 2016, Enhanced Performance and Mode of Action of a Novel Antibiofilm Hydrofiber® Wound dressing

11. Said 2014. An in vitro test of the efficacy of an anti-biofilm wound dressing

12. Chen 2000, Biofilm removal caused by chemical treatments

13. Meredith 2023, Assessment of Silver-Containing Gelling Fiber Dressings Against Antibiotic-Resistant Pathogens Using an in vitro Biofilm Model

14. Beraldo S, Ljungqvist J, Rodger R, Hanson B, Saavedra C. Effectiveness of an enhanced silver-containing dressing in hard-to-heal venous leg ulcers: a randomised controlled trial. J Wound Care. 2025;34(3):170-178.

15. Meaume S, Truchetet F, Cambazard F, et al. A radomized controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers. Wound Repair and Regeneration. 2012;20(4):500-511. doi:10.1111/j.1524-475X.2012.00797.x

AP-76380-GBR-ENG-v1

Blogs

See all

05/09/2024

Wound healing in hard-to-heal cases

Despite advances in dressing technology and best practice, wound care is in crisis. Successful treatment requires an ...

Read more Read more

28/08/2024

How to recognise wound biofilm

Spotting biofilm with the naked eye can be a challenge due to its microscopic structure. Knowing how to recognise wou...

Read more Read more

27/08/2024

Why is biofilm so resistant?

Read our latest blog to learn what makes biofilm a tricky customer and how the right wound dressing can destroy it.

Read more Read more

09/09/2024

How does biofilm affect wound healing?

In wound healing, the intricate relationship between cellular processes orchestrates the healing journey, but there i...

Read more Read more
See all

You are leaving convatec.com

This Internet site may provide links or references to other sites but Convatec have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

Do you wish to continue?